These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17415901)

  • 21. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 24. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 26. [New biomarkers for cardiovascular risk evaluation].
    Chironi G
    Rev Prat; 2012 Jun; 62(6):783-5. PubMed ID: 22838270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are novel serum biomarkers informative?
    Wilkins JT; Lloyd-Jones DM
    Med Clin North Am; 2012 Jan; 96(1):1-11. PubMed ID: 22391247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New tool refines heart risk prediction. Adding C-reactive protein and family history modernizes and improves the standard risk tool.
    Harv Heart Lett; 2007 May; 17(9):4-5. PubMed ID: 17517984
    [No Abstract]   [Full Text] [Related]  

  • 29. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis.
    Memiş D; Gursoy O; Tasdogan M; Süt N; Kurt I; Türe M; Karamanlioğlu B
    J Clin Anesth; 2007 May; 19(3):186-91. PubMed ID: 17531726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting cardiovascular risk: so what do we do now?
    Lloyd-Jones DM; Tian L
    Arch Intern Med; 2006 Jul; 166(13):1342-4. PubMed ID: 16831997
    [No Abstract]   [Full Text] [Related]  

  • 31. C-reactive protein and heart attack risk.
    Harv Womens Health Watch; 2000 May; 7(9):7. PubMed ID: 10762537
    [No Abstract]   [Full Text] [Related]  

  • 32. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of CRP in coronary risk determination.
    Mehta JL; Sukhija R; Romeo F; Sepulveda JL
    Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal vasculature findings do not add information about cardiovascular risk.
    de Abreu Silva EO
    Arch Intern Med; 2007 Jun; 167(11):1209-10; author reply 1210. PubMed ID: 17563036
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiovascular risk factors--where do these come from? Interview by Nicola von Lutterotti].
    Assmann G
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():33-4. PubMed ID: 16379234
    [No Abstract]   [Full Text] [Related]  

  • 37. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Hage FG; Szalai AJ
    J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
    May A; Wang TJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The search for new cardiovascular biomarkers.
    Gerszten RE; Wang TJ
    Nature; 2008 Feb; 451(7181):949-52. PubMed ID: 18288185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.